Adaptimmune Competitors and Similar CompaniesClear all
Adaptimmune's competitors and similar companies include Bellicum Pharmaceuticals.
 Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. |  Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies. | |
Founding Date | Founding Date 2008 | Founding Date 2004 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB | Locations Houston, US HQ Houston, US Houston, US South San Francisco, US |
Employees | Employees 4007% decrease | Employees 1386% increase |
Valuation ($) | Valuation ($) 188.5 m | Valuation ($) 778.3 k |
Financial | ||
Revenue (est.) | Revenue (est.) $178m (FY, 2024) | Revenue (est.) $1.5m (FY, 2022) |
Net income | Net income ($70.8m) (FY, 2024) | Net income ($25m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Bellicum Pharmaceuticals
HQ
Houston, US
Employees
13
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
View company